Browse by Journal or Publication Title

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Creators | Item Type | No Grouping
Jump to: A | G | J | K | L | N | R | S | T
Number of items: 13.

A

Atan, D, Foy, C and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2008) Reply to ‘Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy’. Eye, 22 (3). p. 471. doi:10.1038/sj.eye.6703019

G

Gale, R, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Evans, M, Ghanchi, F, Yang, Y, Silvestri, G, Freeman, M, Maisey, A and Napier, J (2017) Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease. Eye, 31 (S1). S1-S20. doi:10.1038/eye.2017.53

J

Jones, Rebecca, Stratton, Irene M, Scanlon, Peter H ORCID: 0000-0001-8513-710X and Theodoropoulou, Sofia (2023) Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration. Eye, 37 (15). pp. 3186-3190. doi:10.1038/s41433-023-02474-3

K

Keenan, T D, Johnston, R L, Donachie, P H, Sparrow, J M, Stratton, I M and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2013) United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services. Eye, 27 (12). pp. 1397-1404.

L

Leal, Jose, Luengo-Fernandez, Ramon, Stratton, Irene M., Dale, Angela, Ivanova, Katerina and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2019) Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy. Eye, 33 (4). pp. 640-647. doi:10.1038/s41433-018-0297-7

N

Nevill, Clareece R., Stratton, Irene M., Maruti, Sonia S., Massó-González, Elvira L., Sivaprasad, Sobha, Bailey, Clare, Ehrlich, Michael, Chong, Victor and Scanlon, Peter H ORCID: 0000-0001-8513-710X (2022) Epidemiology of moderately severe and severe non-proliferative diabetic retinopathy in South West England. Eye, 36 (2). pp. 433-440. doi:10.1038/s41433-021-01471-8

R

Ross, A H, Donachie, P H J, Sallam, A, Stratton, I M, Mohamed, Q, Scanlon, Peter H ORCID: 0000-0001-8513-710X, Kirkpatrick, J N and Johnston, R L (2013) Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab? Eye, 27 (1). pp. 56-64. doi:10.1038/eye.2012.225

S

Scanlon, Peter H ORCID: 0000-0001-8513-710X (2010) Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy? Eye, 24 (3). pp. 435-440. doi:10.1038/eye.2009.320

Scanlon, Peter H ORCID: 0000-0001-8513-710X, Norridge, Charlotte F. E., Donachie, Paul H. J. and Mohamed, Quresh (2022) Should we still be performing macular laser for non-centre involving diabetic macular oedema? Results from a UK centre. Eye, 36 (3). pp. 646-648. doi:10.1038/s41433-021-01789-3

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb and Napier, Jackie (2023) Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes. Eye, 37. pp. 2753-2760. doi:10.1038/s41433-023-02409-y

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb and Napier, Jackie (2022) Evaluation of standard of care intravitreal aflibercept treatment of diabetic macular oedema treatment-naive patients in the UK: DRAKO study 12-month outcomes. Eye, 36. pp. 64-71. doi:10.1038/s41433-021-01624-9

Sivaprasad, Sobha, Ghanchi, Faruque, Kelly, Simon P., Kotagiri, Ajay, Talks, James, Scanlon, Peter H ORCID: 0000-0001-8513-710X, McGoey, Hellen, Nolan, Andrew, Saddiq, Moneeb, Napier, Jackie and Morgan-Warren, Peter (2023) Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes. Eye, 37 (12). pp. 2527-2534. doi:10.1038/s41433-022-02367-x

T

Talks, S. J., Stratton, I., Peto, T., Lotery, A., Chakravarthy, U., Eleftheriadis, H., Izadi, S., Dhingra, N., Scanlon, Peter H ORCID: 0000-0001-8513-710X, Talks, James, Mohamed, Quresh, Lotery, Andrew, Kashani, Sharam, Georgas, Nasos, Jones, Colin, Gashut, Abdisattar, Santiago, Cynthia, Chhabra, Romi, Antcliff, Richard, Dhingra, Naren, Bailey, Clare, Chakravarthy, Usha, Peto, Tunde, Ghanchi, Faruque, Mcinerney, Linda, Natha, Salim, Khan, Rehna, Dias, Indra, Mukhrejee, Raj, Izadi, Shahrnaz, Tahir, Irfan and Eleftheriadis, Haralabos (2022) Aflibercept in clinical practice; visual acuity, injection numbers and adherence to treatment, for diabetic macular oedema in 21 UK hospitals over 3 years. Eye, 36. pp. 72-77. doi:10.1038/s41433-021-01625-8

This list was generated on Fri Mar 29 04:48:28 2024 UTC.

University Of Gloucestershire

Bookmark and Share

Find Us On Social Media:

Social Media Icons Facebook Twitter Google+ YouTube Pinterest Linkedin

Other University Web Sites

University of Gloucestershire, The Park, Cheltenham, Gloucestershire, GL50 2RH. Telephone +44 (0)844 8010001.